Adlai Nortye
is a China-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and metabolic diseases... Read moreAdlai Nortye
is a China-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and metabolic diseases... Read more
News
Apr 10, 2025
Benzinga
Adlai Nortye: Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025
Sep 09, 2024
Zacks
Adlai Nortye: Adlai Nortye Ltd. Sponsored ADR (ANL) Loses -33.06% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Sep 08, 2024
Americanbankingnews
Adlai Nortye: Analysts Set Expectations for Adlai Nortye Ltd.'s FY2024 Earnings (NASDAQ:ANL)
Aug 09, 2024
Seeking Alpha
Adlai Nortye: Adlai Nortye reports 1H results
Jul 03, 2024
MarketScreener
Adlai Nortye: Adlai Nortye : Management Changes of the Company Form 6 K
Jun 17, 2024
Pharamceutical Technology
Adlai Nortye: Buparlisib hydrochloride by Adlai Nortye Biopharma for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
May 24, 2024
MarketScreener
Adlai Nortye: Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
May 23, 2024
Clinical Trials Arena
Adlai Nortye: Adlai Nortye starts subject dosing in Phase II rectal cancer trial
Dec 06, 2023
MarketScreener
Adlai Nortye: Adlai Nortye : Term of use
Nov 18, 2023
Life Care News
Adlai Nortye: Adlai Nortye Announces Completion of Patient Enrollment in
Adlai Nortye Competitors
1
2
3
4
5
6
7
8